Astrana Health (ASTH) Capital Expenditures (2011 - 2026)

Astrana Health (ASTH) has 16 years of Capital Expenditures data on file, last reported at $4.0 million in Q1 2026.

• Quarterly Capital Expenditures rose 30.29% year-over-year to $4.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.0 million (up 2.83% YoY) and the FY2025 annual result came in at $10.1 million, up 25.84% from the prior year.
• Capital Expenditures improved to $4.0 million in Q1 2026 per ASTH's latest filing, from $3.1 million in the prior quarter.
• The five-year high for Capital Expenditures was $22.9 million in Q4 2022, with the low at -$18.8 million in Q3 2022.
• Average Capital Expenditures over 5 years is $4.3 million, with a median of $3.1 million recorded in 2025.
• The widest YoY moves for Capital Expenditures: up 17745.92% in 2022, down 308.09% in 2022.
• Astrana Health's Capital Expenditures stood at $22.9 million in 2022, then tumbled by 69.24% to $7.1 million in 2023, then plunged by 64.13% to $2.5 million in 2024, then rose by 21.06% to $3.1 million in 2025, then jumped by 30.55% to $4.0 million in 2026.
• Business Quant data shows ASTH's Capital Expenditures at $4.0 million in Q1 2026, $3.1 million in Q4 2025, and $2.6 million in Q3 2025.